ArticleExperimental and therapeutic medicine2014

Randomized controlled clinical trial of a combination therapy of vildagliptin plus an α-glucosidase inhibitor for patients with type II diabetes mellitus.

Yong Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.